{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:42Z","timestamp":1790787522954,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Nearly all cases of cervical cancer are caused by persistent infection with high-risk human papillomavirus (HPV), and many cases of invasive cancer have been attributed to lack of screening. Transmasculine and nonbinary patients are more likely to be underscreened than cisgender women for a variety of reasons, and high-risk HPV self-sampling has been proposed as a method to increase screening uptake in this population. This narrative review is among the first to assess HPV self-sampling as a cervical cancer screening modality in transmasculine and nonbinary populations. Self-sampling for HPV detection is highly accepted in transmasculine and nonbinary populations, with the majority preferring self-sampling to any form of clinician-collected samples, although preferences varied across studies and choice of methods is important. In one study, offering the option to self-sample increased adherence to cervical cancer screening for transmasculine and nonbinary patients. More research is needed to further guide follow-up recommendations and to show the long-term effect of this modality on adherence to screening. Clinicians caring for transmasculine and nonbinary patients should feel comfortable offering high-risk HPV self-testing as an option for cervical cancer screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006296","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:00:36Z","timestamp":1777582836000},"page":"32-42","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Self-Sampling for Cervical Cancer Screening in Transmasculine and Nonbinary People"],"prefix":"10.1097","volume":"148","author":[{"given":"Madelyn","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Rusley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20260930","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260930","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/cncr.34487","article-title":"Current gaps and opportunities in screening, prevention, and treatment of cervical cancer","volume":"128","author":"Rimel","year":"2022","journal-title":"Cancer"},{"key":"R3-20260930","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R4-20260930","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2020.08.033","article-title":"A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States","volume":"159","author":"Landy","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R5-20260930","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nwh.2017.12.008","article-title":"A literature review of cervical cancer screening in transgender men","volume":"22","author":"Gatos","year":"2018","journal-title":"Nurs Womens Health"},{"key":"R6-20260930","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/1471-0528.16503","article-title":"Cervical cancer prevention in transgender men: a review","volume":"128","author":"Weyers","year":"2021","journal-title":"BJOG"},{"key":"R7-20260930","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.amepre.2014.07.031","article-title":"Pap test use is lower among female-to-male patients than non-transgender women","volume":"47","author":"Peitzmeier","year":"2014","journal-title":"Am J Prev Med"},{"key":"R8-20260930","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/ajo.13674","article-title":"Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand","volume":"63","author":"Carroll","year":"2023","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R9-20260930","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1080\/13691058.2019.1677942","article-title":"Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers","volume":"22","author":"Peitzmeier","year":"2020","journal-title":"Cult Health Sex"},{"key":"R10-20260930","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1177\/1049732317725513","article-title":"\u201cIt can promote an existential crisis\u201d: factors influencing Pap test acceptability and utilization among transmasculine individuals","volume":"27","author":"Peitzmeier","year":"2017","journal-title":"Qual Health Res"},{"key":"R11-20260930","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/trgh.2016.0024","article-title":"Transgender noninclusive healthcare and delaying care because of fear: connections to general health and mental health among transgender adults","volume":"2","author":"Seelman","year":"2017","journal-title":"Transgender Health"},{"key":"R12-20260930","first-page":"1","article-title":"Transgender competent provider: identifying transgender health needs, health disparities, and health coverage","volume":"11","author":"Houssayni","year":"2018","journal-title":"Kans J Med"},{"key":"R13-20260930","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11606-013-2753-1","article-title":"Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening","volume":"29","author":"Peitzmeier","year":"2014","journal-title":"J Gen Intern Med"},{"key":"R14-20260930","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1007\/s11606-024-09026-9","article-title":"Strategies to optimize cervical cancer screening rates among transgender and gender-diverse people assigned female at birth","volume":"39","author":"Fosmore","year":"2024","journal-title":"J Gen Intern Med"},{"key":"R15-20260930","doi-asserted-by":"crossref","first-page":"106071","DOI":"10.1016\/j.ypmed.2020.106071","article-title":"Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review","volume":"135","author":"Connolly","year":"2020","journal-title":"Prev Med"},{"key":"R16-20260930","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/13691058.2016.1177203","article-title":"Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives","volume":"18","author":"Ag\u00e9nor","year":"2016","journal-title":"Cult Health Sex"},{"key":"R17-20260930","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MED.0000000000000227","article-title":"Barriers to healthcare for transgender individuals","volume":"23","author":"Safer","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R18-20260930","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/LGT.0000000000000763","article-title":"Understanding sexual and gender minority populations and organ-based screening recommendations for human papillomavirus\u2013related cancers","volume":"27","author":"Jodry","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"R19-20260930","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000004294","article-title":"Health care for transgender and gender diverse individuals. ACOG Committee Opinion No. 823. American College of Obstetricians and Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R21-20260930","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/LGT.0000000000000614","article-title":"The ASCCP Cervical Cancer Screening Task Force endorsement and opinion on the American Cancer Society updated cervical cancer screening guidelines","volume":"25","author":"Marcus","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"R23-20260930","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/LGT.0000000000000804","article-title":"Enduring consensus guidelines for cervical cancer screening and management: introduction to the scope and process","volume":"28","author":"Wentzensen","year":"2024","journal-title":"J Low Genit Tract Dis"},{"key":"R24-20260930","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","article-title":"The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis","volume":"93","author":"Nelson","year":"2017","journal-title":"Sex Transm Infect"},{"key":"R25-20260930","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/LGT.0000000000000476","article-title":"Acceptability of women self-sampling versus clinician-collected samples for HPV DNA testing: a systematic review","volume":"23","author":"Morgan","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"R26-20260930","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1158\/1055-9965.EPI-20-0306","article-title":"Variation in cervical cancer screening preferences among medically underserved individuals in the United States: a systematic review","volume":"29","author":"Biddell","year":"2020","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"R27-20260930","doi-asserted-by":"crossref","first-page":"e1914729","DOI":"10.1001\/jamanetworkopen.2019.14729","article-title":"Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial","volume":"2","author":"Winer","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"R28-20260930","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10900-024-01401-1","article-title":"Evaluation of human papillomavirus vaccination and cancer prevention behaviors among LGBTQI + individuals: a cross-sectional study","volume":"50","author":"Rana","year":"2025","journal-title":"J Community Health"},{"key":"R29-20260930","doi-asserted-by":"crossref","first-page":"106400","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups","volume":"144","author":"Fuzzell","year":"2021","journal-title":"Prev Med"},{"key":"R30-20260930","doi-asserted-by":"crossref","first-page":"e70033","DOI":"10.1002\/cam4.70033","article-title":"A qualitative assessment of the acceptability of human papillomavirus self-sampling and informational materials among diverse populations","volume":"13","author":"Petrik","year":"2024","journal-title":"Cancer Med"},{"key":"R31-20260930","doi-asserted-by":"crossref","first-page":"101702","DOI":"10.1016\/j.eclinm.2022.101702","article-title":"HPV screening in the urine of transpeople\u2013a prevalence study","volume":"54","author":"Pils","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R33-20260930","doi-asserted-by":"crossref","first-page":"e0190172","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"R34-20260930","doi-asserted-by":"crossref","DOI":"10.1089\/lgbt.2023.0336","article-title":"Cervicovaginal and anal self-sampling for human papillomavirus testing in a transgender and gender diverse population assigned female at birth: comfort, difficulty, and willingness to use","author":"Welsh","year":"2024","journal-title":"LGBT Health."},{"key":"R35-20260930","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/lgbt.2016.0187","article-title":"Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered Pap tests","volume":"4","author":"McDowell","year":"2017","journal-title":"LGBT Health"},{"key":"R36-20260930","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/lgbt.2016.0143","article-title":"Understanding transgender men's experiences with and preferences for cervical cancer screening: a rapid assessment survey","volume":"4","author":"Seay","year":"2017","journal-title":"LGBT Health"},{"key":"R37-20260930","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/23293691.2022.2094737","article-title":"\u201cDoing it on my own terms\u201d: transgender and nonbinary adults' experiences with HPV self-swabbing home testing kits","volume":"10","author":"Kattari","year":"2023","journal-title":"Womens Reprod Health (Phila)"},{"key":"R38-20260930","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.3399\/BJGP.2020.0905","article-title":"Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK","volume":"71","author":"Berner","year":"2021","journal-title":"Br J Gen Pract"},{"key":"R40-20260930","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/lgbt.2019.0202","article-title":"Cervical cancer screening with human papillomavirus self-sampling among transgender men in El Salvador","volume":"7","author":"Maza","year":"2020","journal-title":"LGBT Health"},{"key":"R41-20260930","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/trgh.2019.0019","article-title":"Improved rates of cervical cancer screening among transmasculine patients through self-collected swabs for high-risk human papillomavirus DNA testing","volume":"5","author":"Goldstein","year":"2020","journal-title":"Transgender Health"},{"key":"R42-20260930","doi-asserted-by":"crossref","first-page":"101875","DOI":"10.1016\/j.cpr.2020.101875","article-title":"The phenomenology of gender dysphoria in adults: a systematic review and meta-synthesis","volume":"80","author":"Cooper","year":"2020","journal-title":"Clin Psychol Rev"},{"key":"R43-20260930","doi-asserted-by":"crossref","first-page":"1241015","DOI":"10.3389\/fpain.2024.1241015","article-title":"Pain mechanisms in the transgender individual: a review","volume":"5","author":"Anger","year":"2024","journal-title":"Front Pain Res"},{"key":"R44-20260930","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/LGT.0000000000000885","article-title":"Self-collected vaginal specimens for HPV testing: recommendations from the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee","volume":"29","author":"Wentzensen","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"R46-20260930","doi-asserted-by":"crossref","first-page":"1003461","DOI":"10.3389\/fpubh.2022.1003461","article-title":"Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials","volume":"10","author":"Di Gennaro","year":"2022","journal-title":"Front Public Health"},{"key":"R47-20260930","doi-asserted-by":"crossref","first-page":"e001351","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ Glob Health"},{"key":"R48-20260930","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/ijc.34902","article-title":"The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer screening programme","volume":"154","author":"Olthof","year":"2024","journal-title":"Int J Cancer"},{"key":"R49-20260930","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:01:49Z","timestamp":1790784109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006296","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}